Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study (Q80462375)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

Albert Hofman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Cornelia M. van Duijn

4

object named as

Cornelia M van Duijn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Ronald van der Knaap

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Claire Siemes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jan-Willem W Coebergh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Bruno H Ch Stricker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

748-757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin receptors: a new role in cancer?

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Angiotensin converting enzyme inhibitors for cancer treatment?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Increased angiotensin II type-2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Do calcium channel blockers increase the risk of cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Calcium-channel blockers and risk of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

A cohort study of antihypertensive medication use and breast cancer among Danish women.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65–79 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Breast cancer incidence and use of antihypertensive medication in women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Antihypertensive drug use and the risk of prostate cancer (Canada)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Association between captopril, other antihypertensive drugs and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Antihypertensive therapy and the risk of malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

A study of gene--environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Determinants of disease and disability in the elderly: The Rotterdam elderly study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23215

7 January 2021

Identifiers

DOI

10.1002/CNCR.23215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181094%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference